Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI

OBJECTIVE: To assess the diagnostic value of gadolinium (Gd) contrast administration in MRI follow-up examinations of patients with MS if the T2 lesion load is stable. METHODS: We included 100 patients with MS with at least 2 cranial MRI follow-up examinations (mean follow-up time 4.0 ± 2.6 years)....

Descripción completa

Detalles Bibliográficos
Autores principales: Karimian-Jazi, Kianush, Wildemann, Brigitte, Diem, Ricarda, Schwarz, Daniel, Hielscher, Thomas, Wick, Wolfgang, Bendszus, Martin, Breckwoldt, Michael O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053940/
https://www.ncbi.nlm.nih.gov/pubmed/30038948
http://dx.doi.org/10.1212/NXI.0000000000000480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053940/
https://www.ncbi.nlm.nih.gov/pubmed/30038948
http://dx.doi.org/10.1212/NXI.0000000000000480

Ejemplares similares